Respect-LM Dose Optimization Trial Shows Success in Treating Leptomeningeal Metastases
Plus Therapeutics has begun treating the first patients in its ReSPECT-LM dose optimization trial for REYOBIQ™, a targeted radiotherapeutic...
eClinical Tech News
Ultragenyx, Mereo Biopharma UX143 Orbit Study Final Analysis
Ultragenyx and Mereo BioPharma announced that the Phase 3 Orbit study of setrusumab for osteogenesis imperfecta (OI) in pediatric...
Tonix Publishes Phase 3 Fibromyalgia Trial Results of TNX-102 SL
Tonix Pharmaceuticals announced positive Phase 3 RESILIENT trial results for TNX-102 SL (sublingual cyclobenzaprine HCl tablets) in managing fibromyalgia...
Sil204 Shows Efficacy in Human Lung Cancer Cell Lines
Silexion Therapeutics (NASDAQ: SLXN) announced positive preclinical data for SIL204, its RNA interference (RNAi) therapy, in human lung cancer...
Seclidemstat’s Role in LSD1 Inhibition Validated in Oncology Studies
Salarius Pharmaceuticals announced positive preclinical data on its LSD1 inhibitor, seclidemstat, and provided an update on its merger with...
BioVie’s Bezisterim Shows Potential to Slow or Reverse Aging
BioVie Inc. presented data from its Phase 3 NM101 study on bezisterim, a drug candidate for Alzheimer’s diseaseAlzheimer’s disease,...
Zervimesine in Alzheimer’s: Cognition Therapeutics and FDA Discuss Phase 2
Cognition Therapeutics met with the FDA to discuss Phase 2 trial results for their Alzheimer’s drug, zervimesine (CT1812), and...
Artelo Biosciences: Positive Preclinical Efficacy of ART12.11 in Stress-Induced Depression
Artelo Biosciences announced preclinical data for its CBD-TMP cocrystal drug, ART12.11, at the International Cannabinoid Research Society Symposium. The...
Briquilimab Shows Promising Results in Chronic Urticaria Studies
Jasper Therapeutics has reported updated data from its BEACON Phase 1b/2a study of briquilimab, a subcutaneous antibody therapy for...
Bezuclastinib Shows Positive Top-Line Results in Summit Trial
Cogent Biosciences announced positive top-line results from its SUMMIT clinical trial of bezuclastinib for non-advanced systemic mastocytosis (NonAdvSM). The...